Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 1;24(1):52.
doi: 10.1186/s12933-025-02616-9.

Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes

Affiliations

Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes

Yiheng Zhang et al. Cardiovasc Diabetol. .

Abstract

Background: The prognostic significance of triglyceride-glucose (TyG)-related indices in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) combined with prediabetes or diabetes is not yet fully understood. In this study, we explored their predictive value for mortality in this specific population.

Methods: Patients with MASLD were identified from the National Health and Nutrition Examination Survey (NHANES III) database. TyG and its related parameters [TyG-waist circumference (TyG-WC), TyG-waist-to-height ratio (TyG-WHtR), TyG-weight-adjusted waist index (TyG-WWI), and TyG-body mass index (TyG-BMI), ] were calculated. To examine the association between TyG-related indices and mortality risk, Cox regression models were utilized. Furthermore, we employed restricted cubic spline (RCS) analysis to investigate potential dose-response relationships. The predictive ability of the TyG indices for mortality was assessed by analyzing the time-dependent area under the curve (AUC).

Results: In the cohort of patients with prediabetes or diabetes, 46.5% were diagnosed with MASLD. Over a median follow-up of 25.4 years, 1,163 individuals (53.9%) died, with 329 (15.3%) deaths attributed to cardiovascular causes and 78 (3.6%) to diabetes. Multivariate Cox regression models showed that TyG, TyG-BMI, TyG-WHtR, TyG-WWI, and TyG-WC were associated with all-cause and cardiovascular/diabetes-specific mortality. Furthermore, RCS analysis revealed a positive linear relationship between the TyG and TyG-WWI indices and all-cause mortality (p for nonlinear = 0.920; p = 0.525, respectively). In contrast, the TyG-WC, TyG-BMI, and TyG-WHtR indices exhibited a positive nonlinear association with all-cause mortality (p for nonlinear = 0.001; = 0.003; = 0.007, respectively). Time-dependent AUC curves demonstrated that the TyG-WWI index was the most robust predictor of both all-cause and cardiovascular mortality.

Conclusions: Elevated levels of TyG, TyG-BMI, TyG-WHtR, TyG-WWI, and TyG-WC indices were associated with a poorer prognosis in MASLD patients with prediabetes or diabetes, with TyG-WWI being the strongest predictor.

Keywords: Diabetes; MASLD; Mortality; Triglyceride-glucose related indices.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: NHANES was conducted with approval by the National Center for Health Statistics Ethics Review Board, and obtained informed written consent from all the individuals involved in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart for selection of study population
Fig. 2
Fig. 2
RCS curves were employed to illustrate the correlation between TyG-related indices and all-cause mortality in MASLD patients with prediabetes or diabetes, adjusting for factors such as age, sex, ethnicity, family income ratio, marital status, education level, smoking, and FIB-4. A TyG index; B TyG-BMI index; C TyG-WHtR index; D TyG-WWI index; E TyG-WC index. Abbreviations: MASLD, Metabolic Dysfunction-Associated Steatotic Liver Disease; TyG, Triglyceride-glucose; BMI, Body mass index; WHtR, Waist-height ratio; WWI, Weight-adjusted waist index; WC, waist circumference; RCS, Restricted cubic spline; FIB-4, Fibrosis-4 index.
Fig. 3
Fig. 3
Time-dependent AUC curves assessing the predictive power of the TyG correlation index for all-cause and cause-specific mortality in MASLD patients with prediabetes or diabetes. A All-cause mortality; B Cardiovascular mortality; C Diabetes mortality. Abbreviations: MASLD, Metabolic Dysfunction-Associated Steatotic Liver Disease; AUC, Area under the curve; TyG, Triglyceride-glucose; BMI, Body mass index; WHtR, Waist-height ratio; WWI, Weight-adjusted waist index; WC, waist circumference.
Fig. 4
Fig. 4
Subgroup analysis of the correlation between TyG-related indices and all-cause mortality in MASLD patients with prediabetes or diabetes. A TyG index; B TyG-BMI index; C TyG-WHtR index; D TyG-WWI index; E TyG-WC index. Abbreviations: MASLD, Metabolic Dysfunction-Associated Steatotic Liver Disease; TyG, Triglyceride-glucose; BMI, Body mass index; WHtR, Waist-height ratio; WWI, Weight-adjusted waist index; WC, waist circumference.

Similar articles

Cited by

References

    1. Eslam M, Sanyal AJ, George J, International Consensus Panel. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–e20141. - PubMed
    1. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966–86. - PMC - PubMed
    1. Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18(9):599–612. - PubMed
    1. Tanase DM, Gosav EM, Costea CF, et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res. 2020;2020:3920196. - PMC - PubMed
    1. Kim H, Lee DS, An TH, et al. Metabolic spectrum of liver failure in type 2 diabetes and obesity: from NAFLD to NASH to HCC. Int J Mol Sci. 2021;22(9):4495. - PMC - PubMed

MeSH terms

LinkOut - more resources